Back to results
US 10,328,079 B2Granted
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy
AssigneeIsofol Medical AB
InventorsPer L. Lindberg, Anders Vedin, Gunnel E. Sundén, Bengt Gustavsson
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment of solid tumors in humans such as cancer, especially colorectal cancer (CRC), which involves administering multiple boluses of the diastereomerically pure folate adjuvant [6R]-5,10-methylenetetrahydrofolate in 5-fluorouracil (5-FU) based chemotherapy.
Claims23
A method of treating a human diagnosed with a solid tumor, which method comprises:
- a) on Day 1, administering an IV bolus containing 10-1000 mg/m2 5-fluorouracil (5-FU) or a fluorinated pyrimidine base, followed, either simultaneously or after a period of 10 min-4 hours, by
- b) administering two or more IV boluses, interspaced by a period of 10-60 minutes, each containing 5-1000 mg/m2 [6R]-5,10-methylenetetrahydrofolate (6R-MTHF) on Day 1, followed by
- c) administering a continuous infusion of 5-FU or a fluorinated pyrimidine base over a period of 46 hours, or until the end of Day 2, followed by
- d) optionally administering one IV bolus containing 5-1000 mg/m2 6R-MTHF before the end of Day 1, followed by
- e) on Day 2, optionally administering one or more IV boluses each containing 5-1000 mg/m2 6R-MTHF,
- wherein step (b) is optionally repeated up to 4 times on Day 1 with an interval of 10 min-4 hours between each repetition, and wherein step (e) is optionally repeated up to 4 times on Day 2 with an interval of between 10 min-60 min between each bolus being administered, and wherein all steps (a)-(e) are optionally repeated every 2 weeks for up to eight (8) cycles.
3 more elements
Dependencies are inferred from the claim text.